Fact Sheet


The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society. As a community, ARM builds the future of medicine by convening the sector, facilitating influential exchanges on policies and practices, and advancing the narrative with data and analysis.

We actively engage key stakeholders to enable the development of advanced therapies and to modernize healthcare systems so that patients benefit from durable, potentially curative treatments. As the global voice of the sector, we represent more than 400 members across 25 countries, including emerging and established biotechnology companies, academic and medical research institutions, and patient organizations.


The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society. As a community, ARM builds the future of medicine by convening the sector, facilitating influential exchanges on policies and practices, and advancing the narrative with data and analysis.

We actively engage key stakeholders to enable the development of advanced therapies and to modernize healthcare systems so that patients benefit from durable, potentially curative treatments. As the global voice of the sector, we represent more than 400 members across 25 countries, including emerging and established biotechnology companies, academic and medical research institutions, and patient organizations.

What Is Regenerative Medicine?

Regenerative medicine includes gene therapies, cell therapies, and tissue-engineered therapies intended to augment, repair, replace, or regenerate organs, tissues, cells, genes, and metabolic processes in the body.

Regenerative medicine aims to alter the current practice of medicine by treating the root causes of disease and disorders.

The regenerative medicine and advanced therapies sector is creating transformative, durable treatments and potential cures for some of humankind’s most devastating diseases – many currently untreatable via conventional treatments – through the use of ground-breaking scientific discoveries and technologies.

 

ARM’s Multi-Stakeholder Membership

Diversity of Organizations (n=425) Diversity of Technology Focus (n=425)
Corporations (Revenue < $50M, <100 FTEs)

50%

Gene Therapy

24%

Corporations (Revenue < $50M, >100 FTEs)

14%

Cell Therapy

29%

Corporations (Revenue > $50M)

9%

Cell & Gene Therapy

5%

Non-Profit Institutions

18%

Tissue Engineering

8%

Academic

5%

CMOs and CROs

13%

Affiliates & Financial Institutions

5%

Service Providers

9%

Advocacy Organizations

6%

Research Organizations

4%

Medical Device

2%

ARM is a tax-exempt, social welfare organization as described by Internal Revenue Code (IRC) section 501(c)(4). As a 501(c)(4) organization, ARM is a not-for-profit organization, and operates to promote social welfare. To that end, seeking legislation germane to the ARM’s programs is a permissible means of attaining social welfare purposes, per section 501(c)(4) of the Internal Revenue Code (IRC).